지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록· 키워드
오류제보하기
Flight crews are exposed to unnatural environment with high altutude and life-style factors that may influence their health status and mortality. Epidemiologic cohort studies of cancer incidence and mortality among flight crew is not quite different from general population and sometimes even better and treatment policy is generally same with the population. But in the matter of back-to-work after treatment it is much different from usual occupation in that working environment of flight crew is much more severe and hazadous. So flight crew who suffers from cancer should be handled differently because of their profession. Flight crew who suffers from cancer is supposed to be excluded from duty at least 1 year after the completion of anticancer treatment irrespective of its modality such as surgery, radiation or chemotherapy. During that time of grounding the crew patient will have recovery time from side effects of treatment and he or she will have surveillence check of cancer recurrence. After that time Flight crew who is proven to be cured from cancer can be allowed to back-to-work with condition. Because anticancer chemotherapy is applied to the most cancers the residual side effects should be taken into account when determining back-to-work. Nowadays long term cancer survivors become common so long term side effects of chemotherapy such as secondary cancer, chronic residual organ damage such as cardiac toxicity or neuronal damage is worthy to be concerned. While cancer is a fatal disease we achieve improvement of cancer treatment and developments in aviation technology as well. Those lead us to face with changing standards for flight crew who have cancer treatment.
목차
I. 서론
II. 연구방법
III. 공중 근무자들에서의 영향
IV. 고찰 및 결론
REFERENCES
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Review of The Crew Hours
항공우주의학 학술대회
2023 .06
-
암 치료성적 향상을 위한 제안
대한의사협회지
2017 .01
-
Prediction of Cancer Incidence and Mortality in Korea, 2023
Cancer Research and Treatment
2023 .04
-
Prediction of Cancer Incidence and Mortality in Korea, 2020
Cancer Research and Treatment
2020 .01
-
Prediction of Cancer Incidence and Mortality in Korea, 2021
Cancer Research and Treatment
2021 .01
-
Prediction of Cancer Incidence and Mortality in Korea, 2022
Cancer Research and Treatment
2022 .04
-
Prediction of Cancer Incidence and Mortality in Korea, 2019
Cancer Research and Treatment
2019 .01
-
Prediction of Cancer Incidence and Mortality in Korea, 2017
Cancer Research and Treatment
2017 .01
-
Prediction of Cancer Incidence and Mortality in Korea, 2016
Cancer Research and Treatment
2016 .01
-
한국의 암환자 치료와 관리현황
대한의사협회지
2017 .01
-
Incidence and mortality projections for major cancers among Korean men until 2034, with a focus on prostate cancer
Investigative and Clinical Urology
2022 .03
-
The Association between Cancer Screening and Cancer History among Korean Adults: The 2010–2012 Korea National Health and Nutrition Examination Survey
Korean Journal of Family Medicine
2019 .01
-
National Cancer Control Plan of the Korea: Current Status and the Fourth Plan (2021-2025)
예방의학회지
2023 .05
-
Development of second primary cancer in Korean breast cancer survivors
Annals of Surgical Treatment and Research
2017 .12
-
노인 암 환자의 접근과 관리 원칙
대한 두경부 종양 학술지
2017 .01
-
Feasibility of Household Surveys for Population Risk Assessment of Cancer and Cancer Registration Support
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
Education for Cancer Patient
대한임상종양학회 학술대회지
2015 .02
-
Education for Cancer Patients
대한임상종양학회 학술대회지
2015 .02
-
Projection of Cancer Incidence and Mortality From 2020 to 2035 in the Korean Population Aged 20 Years and Older
예방의학회지
2022 .11
이 논문의 저자 정보
이 논문과 함께 이용한 논문
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2016-513-001414952